ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SBS Source Bio.

17.50
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Source Bio. LSE:SBS London Ordinary Share GB0009739649 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 17.50 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Source BioScience PLC AMENDMENT - Form 8 (DD) - Source BioScience plc (9210J)

15/09/2016 8:30am

UK Regulatory


Source Bioscience (LSE:SBS)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Source Bioscience Charts.

TIDMSBS

RNS Number : 9210J

Source BioScience PLC

15 September 2016

AMMENT

Please be advised that this announcement replaces the version previously released on 14 August 2016 under RNS number 8700J. The number of share options held has been amended to 'nil'. All other information remains unchanged.

FORM 8 (DD)

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

   1.         KEY INFORMATION 
 
 (a) Full name of discloser:          Mr Laurie Turnbull 
                                       (Chairman of Source 
                                       BioScience plc) 
-----------------------------------  --------------------- 
 (b) Owner or controller              N/A 
  of interests and short 
  positions disclosed, if 
  different from 1(a): 
  The naming of nominee 
  or vehicle companies is 
  insufficient. For a trust, 
  the trustee(s), settlor 
  and beneficiaries must 
  be named. 
-----------------------------------  --------------------- 
 (c) Name of offeror/offeree          Source BioScience 
  in relation to whose relevant        plc 
  securities this form relates: 
  Use a separate form for 
  each offeror/offeree 
-----------------------------------  --------------------- 
 (d) Status of person making          Person acting 
  the disclosure:                      in concert with 
  e.g. offeror, offeree,               the offeree 
  person acting in concert 
  with the offeror/offeree 
  (specify name of offeror/offeree) 
-----------------------------------  --------------------- 
 (e) Date dealing undertaken:         13 September 2016 
-----------------------------------  --------------------- 
 (f) In addition to the               N/A 
  company in 1(c) above, 
  is the discloser making 
  disclosures in respect 
  of any other party to 
  the offer? 
  If it is a cash offer 
  or possible cash offer, 
  state "N/A" 
-----------------------------------  --------------------- 
 
   2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

 
 Class of relevant 
  security: 
---------------------------  ------------------------------------- 
                                 Interests        Short positions 
---------------------------  -----------------  ------------------ 
                               Number      %        Number      % 
---------------------------  ----------  -----  -------------  --- 
 (1) Relevant securities 
  owned and/or controlled:    3,048,667   0.8%       nil        - 
---------------------------  ----------  -----  -------------  --- 
 (2) Cash-settled                nil       -         nil        - 
  derivatives: 
---------------------------  ----------  -----  -------------  --- 
 (3) Stock-settled               nil       -         nil        - 
  derivatives (including 
  options) and agreements 
  to purchase/sell: 
---------------------------  ----------  -----  -------------  --- 
 
   TOTAL:                     3,048,667   0.8%       nil        - 
---------------------------  ----------  -----  -------------  --- 
 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

   (b)        Rights to subscribe for new securities (including directors' and other employee options) 

Nil.

   3.         DEALINGS BY THE PERSON MAKING THE DISCLOSURE 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

   (a)        Purchases and sales 

(i) Party to an offer or person acting in concert (except for a principal trader in the same group as a connected adviser)

 
 Class of    Purchase/sale    Number of    Price per 
  relevant                    securities      unit 
  security 
----------  --------------  ------------  ---------- 
    n/a           n/a            n/a          n/a 
----------  --------------  ------------  ---------- 
 

(ii) Principal trader where the sole reason for the connection is that the principal trader is in the same group as a connected adviser

 
    Class       Purchases/       Total           Highest           Lowest 
  of relevant      sales         number            price            price 
   security                   of securities      per unit         per unit 
                                               paid/received    paid/received 
-------------  -----------  ---------------  ---------------  --------------- 
     n/a           n/a            n/a              n/a              n/a 
-------------  -----------  ---------------  ---------------  --------------- 
 
   (b)        Cash-settled derivative transactions 
 
    Class         Product            Nature of            Number         Price 
  of relevant    description          dealing           of reference    per unit 
   security         e.g.        e.g. opening/closing     securities 
                     CFD            a long/short 
                                     position, 
                                increasing/reducing 
                                    a long/short 
                                      position 
-------------  -------------  ----------------------  --------------  ---------- 
     n/a            n/a                 n/a                 n/a           n/a 
-------------  -------------  ----------------------  --------------  ---------- 
 
   (c)        Stock-settled derivative transactions (including options) 
   (i)         Writing, selling, purchasing or varying 
 
    Class         Product        Writing,         Number       Exercise        Type         Expiry    Option 
  of relevant    description    purchasing,    of securities     price     e.g. American,    date      money 
   security       e.g. call      selling,        to which         per         European                 paid/ 
                   option         varying         option         unit           etc.                  received 
                                   etc.           relates                                             per unit 
-------------  -------------  -------------  ---------------  ---------  ----------------  -------  ---------- 
     n/a            n/a            n/a             n/a           n/a            n/a          n/a        n/a 
-------------  -------------  -------------  ---------------  ---------  ----------------  -------  ---------- 
 
   (ii)        Exercise 
 
    Class         Product      Exercising/       Number       Exercise 
  of relevant    description    exercised     of securities     price 
   security       e.g. call      against                       per unit 
                   option 
-------------  -------------  ------------  ---------------  ---------- 
   Ordinary        Share        Exercised       298,667          Nil 
    shares         options 
  of 2 pence 
     each 
-------------  -------------  ------------  ---------------  ---------- 
 
   (d)        Other dealings (including subscribing for new securities) 
 
 Class of     Nature of dealing    Details        Price 
  relevant    e.g. subscription,                 per unit 
  security        conversion                  (if applicable) 
----------  --------------------  --------  ----------------- 
    n/a              n/a             n/a           n/a 
----------  --------------------  --------  ----------------- 
 
   4.         OTHER INFORMATION 
   (a)        Indemnity and other dealing arrangements 
 
 Details of any indemnity or option arrangement, 
  or any agreement or understanding, formal 
  or informal, relating to relevant securities 
  which may be an inducement to deal or refrain 
  from dealing entered into by the party 
  to the offer or person acting in concert 
  making the disclosure and any other person: 
  Irrevocable commitments and letters of 
  intent should not be included. If there 
  are no such agreements, arrangements or 
  understandings, state "none" 
------------------------------------------------ 
 
   None 
------------------------------------------------ 
 
   (b)        Agreements, arrangements or understandings relating to options or derivatives 
 
 Details of any agreement, arrangement or 
  understanding, formal or informal, between 
  the party to the offer or person acting 
  in concert making the disclosure and any 
  other person relating to: 
  (i) the voting rights of any relevant securities 
  under any option; or 
  (ii) the voting rights or future acquisition 
  or disposal of any relevant securities 
  to which any derivative is referenced: 
  If there are no such agreements, arrangements 
  or understandings, state "none" 
-------------------------------------------------- 
 
   None 
-------------------------------------------------- 
 
   (c)        Attachments 

Are any Supplemental Forms attached?

 
 Supplemental Form 8 (Open Positions)   NO 
-------------------------------------  --- 
 Supplemental Form 8 (SBL)              NO 
-------------------------------------  --- 
 
 
 Date of disclosure:    14 September 2016 
---------------------  --------------------- 
 Contact name:          Nick Ash (Company 
                         Secretary) 
---------------------  --------------------- 
 Telephone number:      +44 (0) 115 973 9010 
---------------------  --------------------- 
 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DCCLIFLDAEIELIR

(END) Dow Jones Newswires

September 15, 2016 03:30 ET (07:30 GMT)

1 Year Source Bioscience Chart

1 Year Source Bioscience Chart

1 Month Source Bioscience Chart

1 Month Source Bioscience Chart

Your Recent History

Delayed Upgrade Clock